Worth reading
56In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
3778830578
¥Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of Series 1 and Series 2 unsecured bonds (small-lot private placement with transfer restrictions)
Intended allottee
Name 株式会社JG44 / Subject Series 1 Bonds and Series 2 Bonds / Amount Series 1 Bonds: ¥2,556,265,700; Series 2 Bonds: ¥1,222,564,878
Amount of funds to be raised
Series 1 Bonds: ¥2,556,265,700; Series 2 Bonds: ¥1,222,564,878; total: ¥3,778,830,578. Estimated net proceeds: Not disclosed
Specific use of funds
Repayment of existing borrowings and related expenses
Funds for the tender offer for the Company's own shares and related expensesAmount The full amount paid in for the Series 2 Bonds (¥1,222,564,878) / Scheduled timing of expenditures Settlement and other procedures relating to the tender offer for the Company's own shares, scheduled to commence on 18 November 2026
Offering structure
Underwriter / lead underwriter
株式会社JG44
Payment date
Series 1 Bonds: 16 November 2026; Series 2 Bonds: 8 January 2027
Basis for determining the amount to be paid
¥1 per ¥1 of the principal amount of the bonds
Impact on Business Performance
The Company expects the impact of the issuance of these bonds on its financial results to be immaterial.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Series 1 and Series 2 unsecured bonds (small-lot private placement with transfer restrictions) |
| Issue price and disposal price | ¥1 per ¥1 of the principal amount for both the Series 1 Bonds and Series 2 Bonds |
| Amount of funds to be raised | Series 1 Bonds: ¥2,556,265,700; Series 2 Bonds: ¥1,222,564,878; total: ¥3,778,830,578. Estimated net proceeds: Not disclosed |
| Specific use of funds | Details Repayment of existing borrowings and related expenses / Amount Not disclosed / Scheduled timing of expenditures Not disclosed, Details Funds for the tender offer for the Company's own shares and related expenses / Amount The full amount paid in for the Series 2 Bonds (¥1,222,564,878) / Scheduled timing of expenditures Settlement and other procedures relating to the tender offer for the Company's own shares, scheduled to commence on 18 November 2026 |
| Payment date | Series 1 Bonds: 16 November 2026; Series 2 Bonds: 8 January 2027 |
| Intended allottee | Name 株式会社JG44 / Subject Series 1 Bonds and Series 2 Bonds / Amount Series 1 Bonds: ¥2,556,265,700; Series 2 Bonds: ¥1,222,564,878 |
| Basis for determining the amount to be paid | ¥1 per ¥1 of the principal amount of the bonds |
| Underwriter / lead underwriter | 株式会社JG44 |
| Impact on Business Performance | The Company expects the impact of the issuance of these bonds on its financial results to be immaterial. |
Items this document does not state (19)
Number of shares to be issued or disposed ofTotal issue valueEstimated issuance expensesIntended allottee's holding policyDilution RateTotal number of issued sharesExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To raise funds for the repayment of existing borrowings and related purposes following the successful completion of this tender offer for shares of another company, as well as funds required for settlement and other purposes relating to the tender offer for the Company's own shares.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.